Comparison between 5 mg and 10 mg warfarin loading doses therapy in cardiac care unit patients at Elobied Hospital, Elobied City- Sudan

Khalid M.E. Eltalib; Ngat A  Ahmed; AbdelSalam MH  Elfaki; Tarig Osman Khalafallah  Ahmed; Mohamed A  Agab; Asaad M  Ahmed

doi:10.30574/gscbps.2021.16.2.0253

Authors

Khalid M.E. Eltalib Department of Medicine, Faculty of Medicine, University of Kordofan, El-Obeid, Sudan.
Ngat A Ahmed Department of Hematology, Faculty of Medical Laboratory Science, University of Kordofan, El-Obeid, Sudan.
AbdelSalam MH Elfaki Department of Medicine, Faculty of Medicine, University of Kordofan, El-Obeid, Sudan.
Tarig Osman Khalafallah Ahmed Department of Hematology, Faculty of Medical Laboratory Science, University of Kordofan, El-Obeid, Sudan.
Mohamed A Agab Department of Medicine, Faculty of Medicine, University of Kordofan, El-Obeid, Sudan.
Asaad M Ahmed Deportment of Hematology, College of Medical Laboratory Sciences, University of Science and Technology, Omdurman, Sudan.

DOI:

https://doi.org/10.30574/gscbps.2021.16.2.0253

Keywords:

Warfarin, INR, Loading dose, Cardiac care, Elobied City

Abstract

Background and objectives: Warfarin sodium therapy is usually initiated with a loading dose to reduce the time needed to reach the target international normalized ratio (INR). The right initial dose of warfarin is controversial. This study aimed to determine the best initial dose of warfarin in terms of safety and efficacy.

Patients and methods: This is a prospective hospital-based study. Fifty-nine patients who were admitted to the coronary care unit with clinical indication for warfarin were assigned to use the initial dose of warfarin 5 mg or 10 mg with the target INR of 2-3. An ethical clearance was obtained from the state ministry of health. A written consent was taken from each patient. An INR was measured at baseline and then after 72 hours. The data were then collected using a data sheet including age, gender, baseline INR, initial dose of warfarin, INR after 72 hours and whether the patient developed bleeding or not. Patients on Aspirin and other non-steroidal anti-inflammatory drugs were excluded. The data were analyzed using SPSS version 18.

Results: A total number of 59 patients were enrolled in the study. In this series, 59% of patients were females. The mean age of patients was 56 years. Five mg loading dose was used in 35 of patients (59%) while 10 mg was used in 24 patients (41%). The mean INR after 72 hours was 2.8 for those with the initial dose of 5 mg. For those with the initial loading dose of 10 mg the mean INR after 72 hours was 3.2. Minor bleeding occurred in three patients, two of them used the initial loading dose of 5mg and only one patient from the group of 10mg.

Conclusion: From this study, it seems that 5 mg loading dose of warfarin is reasonable and cost effective; nevertheless, 10mg initial loading dose is not associated with increased risk of bleeding.

Metrics

Metrics Loading ...

References

Suliman, Aboud Ahamed. Evaluation of Haemostatic Changes in Patients with Haert Diseases in Shendi locality. PhD diss., Mohammed Osman Ali Mohammed. 2018.

Ali, Nada Mohammed Ahmed, et al. Alterations in D-Dimer, Prothrombin time and activated partial thromboplastin time as thrombogenesis activity markers in patients with acute myocardial infarction. Open Journal of Blood Diseases. 2016; 6(1): 1-5.

Ali, Nada Mohammed Ahmed, et al. Original Research Article Influence of anticoagulant therapy in assessment of Fibrinolysis activity in post-acute myocardial infarction patients. Sch. Acad. J. Pharm. 2015; 5(1): 14-19.

Mark A. Crowther, Jeff B Ginsberg, Clive Kearon, etal A Randomized. Trial Comparing 5-mg and 10-mg Warfarin Loading Doses Arch Intern Med. 1999; 159(1): 46-48.

Carl Heneghn Sally Tyndel, Clare Bankhead, Yi Wan, David Keeling, Rafael Perera, Alison Ward. Optimal loading dose for the initiation of warfarin: a systematic reviewBMC Cardiovascular Disorders. 2010; 10: 18.

Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology. 2011; 154(3): 311-24.

Eldour, Ahmed Abdalla Agab, et al. Fibrinogen Levels in Hypertensive and Normotensive: A Cross-Sectional Study from El-Obied City, Sudan. Journal of Biosciences and Medicines. 2016; 4(2): 28-32.

Horton Jon D, Bruce M Bushwick. Warfarin therapy: evolving strategies in anticoagulation. American family physician. 1999; 59(3): 635.

Alegre Jan./Mar. Baglin TP, Cousins D, Keeling DM, Perry DJ, Watson HG: Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. Br J Haematol. 2007; 136: 26-29.

Jerry H. Gurwitz, Jerry Avorn, Dennis Ross-Degnan ScD, Igor Choodnovskiy BS, Jack Ansell. / Aging and the Anticoagulant Response to Warfarin Therapy.Ann Intern Med. 1992; 116(11): 901-904.

Lastória S, Fortes AT, Maffei FHA, Sobreira ML, Rollo HA, Moura R, Yoshida WB. Comparison of initial loading doses of 5 mg and 10 mg for warfarin therapy. Jornal Vascular Brasileiro. 2014; 13: 12-17.